Klain, M.; Nappi, C.; De Risi, M.; Piscopo, L.; Volpe, F.; Manganelli, M.; Caiazzo, E.; Bianco, D.; Schlumberger, M.; Cuocolo, A.
Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer. Diagnostics 2021, 11, 1740.
https://doi.org/10.3390/diagnostics11101740
AMA Style
Klain M, Nappi C, De Risi M, Piscopo L, Volpe F, Manganelli M, Caiazzo E, Bianco D, Schlumberger M, Cuocolo A.
Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer. Diagnostics. 2021; 11(10):1740.
https://doi.org/10.3390/diagnostics11101740
Chicago/Turabian Style
Klain, Michele, Carmela Nappi, Marina De Risi, Leandra Piscopo, Fabio Volpe, Mariarosaria Manganelli, Elisa Caiazzo, Davide Bianco, Martin Schlumberger, and Alberto Cuocolo.
2021. "Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer" Diagnostics 11, no. 10: 1740.
https://doi.org/10.3390/diagnostics11101740
APA Style
Klain, M., Nappi, C., De Risi, M., Piscopo, L., Volpe, F., Manganelli, M., Caiazzo, E., Bianco, D., Schlumberger, M., & Cuocolo, A.
(2021). Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer. Diagnostics, 11(10), 1740.
https://doi.org/10.3390/diagnostics11101740
